| Effects of Singing in Chronic Obstructive Pulmonary Disease (NCT00500526) | University of Sao Paulo | 2005-01-01 |
| Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00110071) | Fred Hutchinson Cancer Center | 2005-01-01 |
| Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition (NCT01160042) | Dr. Reddy's Laboratories Limited | 2005-01-01 |
| Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg (NCT00647894) | Mylan Pharmaceuticals Inc | 2005-01-01 |
| G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission (NCT00233961) | Herbert Irving Comprehensive Cancer Center | 2005-01-01 |
| A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the Body (NCT03761407) | Grünenthal GmbH | 2004-12-30 |
| Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide (NCT00102648) | M.D. Anderson Cancer Center | 2004-12-21 |
| Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood Pressure (NCT00099476) | National Center for Complementary and Integrative Health (NCCIH) | 2004-12-10 |
| Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS) (NCT00099463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-09 |
| A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD (NCT00163098) | Pfizer | 2004-12-01 |
| Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia. (NCT00170703) | Northstar Neuroscience | 2004-12-01 |
| Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00376727) | University of California, Davis | 2004-12-01 |
| Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00099060) | National Cancer Institute (NCI) | 2004-12-01 |
| Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain (NCT00129246) | Yale University | 2004-12-01 |
| BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171650) | Boehringer Ingelheim | 2004-12-01 |
| Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00368914) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-12-01 |
| ARQ 501 in Combination With Docetaxel in Patients With Cancer (NCT00099190) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2004-12-01 |
| Study to Investigate Effects of a Herbal Drug Compared to Placebo on Sleep (NCT00997256) | Pascoe Pharmazeutische Praeparate GmbH | 2004-12-01 |
| Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer (NCT00100672) | INSYS Therapeutics Inc | 2004-12-01 |
| Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals (NCT00218049) | National Institute on Drug Abuse (NIDA) | 2004-12-01 |
| Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer (NCT00102622) | M.D. Anderson Cancer Center | 2004-12-01 |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma (NCT00101972) | MacroGenics | 2004-12-01 |
| Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer (NCT00101842) | Eli Lilly and Company | 2004-12-01 |
| Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg (NCT00648076) | Mylan Pharmaceuticals Inc | 2004-12-01 |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00520000) | UNC Lineberger Comprehensive Cancer Center | 2004-12-01 |
| Thyroxine Replacement in Organ Donors (NCT00238030) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2004-12-01 |
| Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors (NCT00388089) | University of California, Davis | 2004-12-01 |
| The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis (NCT01867645) | Medical University of Vienna | 2004-12-01 |
| Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors (NCT00100347) | PRAECIS Pharmaceuticals Inc. | 2004-12-01 |
| Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma (NCT00216437) | James A. Haley Veterans Administration Hospital | 2004-12-01 |
| Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome (NCT01438853) | Altor BioScience | 2004-12-01 |
| Effect of Fruit and Vegetable Concentrates on Endothelial Function in Persons With Metabolic Syndrome (NCT01224743) | Griffin Hospital | 2004-12-01 |
| Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg (NCT00648947) | Mylan Pharmaceuticals Inc | 2004-12-01 |
| Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease (NCT00100334) | PRAECIS Pharmaceuticals Inc. | 2004-12-01 |
| Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions (NCT01149746) | Teva Pharmaceuticals USA | 2004-12-01 |
| Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. (NCT00181545) | Maastricht Radiation Oncology | 2004-12-01 |
| Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma (NCT00354523) | M.D. Anderson Cancer Center | 2004-12-01 |
| Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors (NCT00238173) | OHSU Knight Cancer Institute | 2004-12-01 |
| Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria (NCT00149383) | Mahidol University | 2004-12-01 |
| Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg (NCT00649818) | Mylan Pharmaceuticals Inc | 2004-12-01 |
| Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease (NCT00113243) | Murphy, Michael P., MD | 2004-12-01 |
| Enhanced Motor Recovery Using Serotonergic Agents in Stroke (NCT01751854) | Shirley Ryan AbilityLab | 2004-12-01 |
| Chronic Illness Care Management (CICM) Study In Primary Care (NCT00153829) | C. T. Lamont Primary Care Research Centre | 2004-12-01 |
| Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors (NCT00303732) | Daniel George, MD | 2004-12-01 |
| Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer (NCT00101894) | Amgen | 2004-12-01 |
| Clinical Evaluation of a Wireless Monitoring Device to Reduce Falls in the Elderly and Others at High Risk of Falling (NCT00249743) | NOCwatch International | 2004-12-01 |
| Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer (NCT00101907) | Amgen | 2004-12-01 |
| SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes (NCT00098826) | National Cancer Institute (NCI) | 2004-12-01 |
| A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma (NCT00103779) | Seagen Inc. | 2004-12-01 |
| Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum (NCT00156650) | University of Washington | 2004-12-01 |
| Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People (NCT00100633) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian Origin (NCT02170909) | Boehringer Ingelheim | 2004-12-01 |
| Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (NCT00655655) | Mayo Clinic | 2004-12-01 |
| Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions (NCT01190761) | Actavis Inc. | 2004-12-01 |
| GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis (NCT00457171) | GlaxoSmithKline | 2004-12-01 |
| Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma (NCT00093613) | National Cancer Institute (NCI) | 2004-12-01 |
| A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. (NCT00377741) | Hoffmann-La Roche | 2004-12-01 |
| Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer (NCT00102752) | Threshold Pharmaceuticals | 2004-12-01 |
| Cranberry Juice for Preventing Bacteria in Urine During Pregnancy (NCT00093938) | National Center for Complementary and Integrative Health (NCCIH) | 2004-12-01 |
| Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study (NCT00850018) | UCSF Benioff Children's Hospital Oakland | 2004-12-01 |
| Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer (NCT00209677) | Hokkaido Gastrointestinal Cancer Study Group | 2004-12-01 |
| Study Evaluating Vaccine in Adults With HIV (NCT00195234) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-12-01 |
| Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease (NCT00102115) | Light Sciences LLC | 2004-12-01 |
| Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers (NCT00099450) | Merck Sharp & Dohme LLC | 2004-12-01 |
| Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg (NCT00650169) | Mylan Pharmaceuticals Inc | 2004-12-01 |
| A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer (NCT00147485) | Pfizer | 2004-12-01 |
| Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg (NCT00647712) | Mylan Pharmaceuticals Inc | 2004-12-01 |
| Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease (NCT00206661) | Genzyme, a Sanofi Company | 2004-12-01 |
| Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer (NCT00559429) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-12-01 |
| Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer (NCT00098995) | Peter MacCallum Cancer Centre, Australia | 2004-12-01 |
| Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese (NCT01620450) | Novo Nordisk A/S | 2004-11-20 |
| Safety Study of Interferon Beta 1a to for Acute Stroke (NCT00097318) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-11-17 |
| Study With GW274150 In Patients With Mild Asthma (NCT00273013) | GlaxoSmithKline | 2004-11-15 |
| Family Management of Childhood Diabetes Study (NCT00340938) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2004-11-08 |
| Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma (NCT00118313) | Craig L Slingluff, Jr | 2004-11-04 |
| Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax) (NCT03460730) | KEMRI-Wellcome Trust Collaborative Research Program | 2004-11-04 |
| MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia (NCT00101179) | National Cancer Institute (NCI) | 2004-11-03 |
| Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics (NCT03091868) | Bial - Portela C S.A. | 2004-11-03 |
| BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors (NCT00095459) | National Cancer Institute (NCI) | 2004-11-02 |
| LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures (NCT00144872) | GlaxoSmithKline | 2004-11-01 |
| Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease (NCT00143572) | St. Jude Children's Research Hospital | 2004-11-01 |
| Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer (NCT00145743) | Tumor Center Regensburg | 2004-11-01 |
| A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia (NCT00154089) | Erimos Pharmaceuticals | 2004-11-01 |
| Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer (NCT00100139) | INSYS Therapeutics Inc | 2004-11-01 |
| Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma (NCT00328887) | Weill Medical College of Cornell University | 2004-11-01 |
| Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy (NCT00801177) | Eli Lilly and Company | 2004-11-01 |
| Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions (NCT01149733) | Teva Pharmaceuticals USA | 2004-11-01 |
| Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment (NCT00162097) | Bristol-Myers Squibb | 2004-11-01 |
| Ispinesib In Combination With Capecitabine In Patients With Solid Tumors (NCT00119171) | GlaxoSmithKline | 2004-11-01 |
| Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions (NCT01581879) | Dr. Reddy's Laboratories Limited | 2004-11-01 |
| Phase I Trial of Paclitaxel With Perifosine (NCT00399126) | AEterna Zentaris | 2004-11-01 |
| Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers. (NCT00886002) | Janssen-Cilag A.G., Switzerland | 2004-11-01 |
| Indole-3-Carbinol in Preventing Cancer in Healthy Participants (NCT00100958) | University of Kansas | 2004-11-01 |
| Cognitive Therapy for PTSD in Addiction Treatment (NCT00685451) | Dartmouth-Hitchcock Medical Center | 2004-11-01 |
| Phase I Trial of Docetaxel With Perifosine (NCT00399087) | AEterna Zentaris | 2004-11-01 |
| Hydralazine as a Demethylating Agent in Rectal Cancer (NCT00575640) | University of Arkansas | 2004-11-01 |
| The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions (NCT00830219) | Teva Pharmaceuticals USA | 2004-11-01 |
| A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy (NCT00096551) | National Cancer Institute (NCI) | 2004-11-01 |
| A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions (NCT00871247) | Actavis Inc. | 2004-11-01 |
| Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg (NCT00648466) | Mylan Pharmaceuticals Inc | 2004-11-01 |